UC professor works to create a smartphone COVID-19 test
Aashish Priye pivoted his work to focus on the pandemic
Aashish Priye, a University of Cincinnati assistant professor of chemical engineering, has spent much of his research career developing a smartphone diagnostic device for the rapid detection of viruses.
When the novel coronavirus emerged, Priye turned his focus toward COVID-19. Priye and the UC students in his lab are exploring a smartphone-based DNA analyzer that could allow a user to test themselves at home.
Priye is focused on perfecting a process known as LAMP — loop-mediated isothermal amplification — as a potential alternative to the current process of pathogen detection called polymerase chain reaction (PCR), which has been used for more than 30 years and is mostly done in a lab.
“Today’s gold standard PCR system is a bulky machine that uses a lot of power — we know this can be improved,” Priye said. “Our work is curiosity driven — we aim to create the next generation of microfluidic devices using rapid micro-fabrication techniques.”
Priye is heading up one of 13 research teams, each awarded a phase-one $10,000 planning grant last year in the Digital Futures Anchor Development Program from the UC Office of Research. The anchor teams will carry on their research inside the new Digital Futures space, when it opens in 2022.
Featured image at top: Baldwin Quad on UC's campus. Photo/Corrie Mayer/CEAS Marketing.
Related Stories
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
Nanofiber multidrug offers new strategy for glioblastoma
June 8, 2026
Science and medical outlets highlight multidrug nanofiber to treat glioblastoma developed by the University of Cincinnati and Johns Hopkins Medicine.